毒蛋白、非典型分支杆菌皮肤免疫治疗支气管哮喘临床观察  

CLINICAL OBSERVATION OF THE SKIN IMMUNOTHERAPY WITH TOXIPEPTONE AND NONTVPICAL BRANCH RODS IN BRANCHIAL ASTHMA

作　　者：陈小川 王浦林[2] 

机构地区：[1]湖南省湘潭市中心医院,411200 [2]唐山市妇幼保健院

出　　处：《中国煤炭工业医学杂志》2003年第4期306-307,共2页Chinese Journal of Coal Industry Medicine

摘　　要：目的 探索一种治疗支气管哮喘的新方法。方法 毒蛋白、非典型分支杆菌皮肤免疫7d,监测免疫前后血清γ-干扰素的水平变化。结果 血清γ-干扰素水平较治疗前平均升高71.88％。结论 毒蛋白、非典型分支杆菌皮肤免疫可使血清γ-干扰素水平明显升高,可用于治疗支气管哮喘。objective To investigate a new therapy in bronchial asthma. Methods We have performed Skin immunotherapy for 7 days and screened the serum r-interferon levels before and after immunotherapy. Results The average serum r- in-terferon level has increased 71.88 % . Conclusion The serum r- Interferon level can be significantly increased by skin im-munotheray with toxipeptone and nontypical branch rods , so it can be performed in the treament of bronchial asthma.

关 键 词：毒蛋白 非典型分支杆菌 免疫治疗 支气管哮喘 Γ-干扰素 

分 类 号：R562.25[医药卫生—呼吸系统]